Science

Epigenetic markers linked to psychotherapy response in OCD

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 19/10/2026, 14:25:24 UTC.

Briefings

A 2026 article reports that specific epigenetic markers are associated with how individuals respond to exposure-based psychotherapy for OCD, though the biological mechanisms remain poorly understood. The study identifies distinct molecular signatures that may predict treatment efficacy, offering a potential biological basis for understanding why some patients succeed while others do not.

Key points

• Epigenetic markers are identified as potential predictors of response to exposure-based psychotherapy for OCD.
• The study notes that the biological mechanisms underlying treatment response remain poorly understood.

Context

OCD is a mental health disorder characterized by unwanted, recurring thoughts and repetitive behaviors that can severely interfere with everyday life. Exposure-based psychotherapy is one of the most effective treatments, but the biological mechanisms underlying treatment response remain poorly understood.

Limitations

The evidence is limited to a single article from 2026. The study does not provide specific numbers, dates, or named individuals. The findings are observational and do not confirm causality. The study does not claim to identify specific epigenetic markers or provide a definitive list of predictive factors.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 19/10/2026, 15:03:15 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeigh6f475nvo4otgvnvjge6zsx7np4mm42g444qjdtahcuuyrweup4